Methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate
C21H16N8O2 — CID 135255894
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate
Methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate (PubChem CID 135255894) has the molecular formula C21H16N8O2 and a molecular weight of 412.41 g/mol. Its IUPAC name is methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate.
Molecular Properties
| Compound Name | Methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate |
|---|---|
| PubChem CID | 135255894 |
| Molecular Formula | C21H16N8O2 |
| Molecular Weight | 412.41 g/mol |
| Exact Mass | 412.14 |
| IUPAC Name | methyl 6-[[4-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]triazol-1-yl]methyl]pyridine-2-carboxylate |
| SMILES | COC(=O)c1cccc(Cn2cc(-c3cc(-c4cccc(C#N)c4)nc(N)n3)nn2)n1 |
| InChI | InChI=1S/C21H16N8O2/c1-31-20(30)16-7-3-6-15(24-16)11-29-12-19(27-28-29)18-9-17(25-21(23)26-18)14-5-2-4-13(8-14)10-22/h2-9,12H,11H2,1H3,(H2,23,25,26) |
| InChIKey | USBMWCCCRSEVPN-UHFFFAOYSA-N |
| XLogP | 2.09 |
| TPSA | 145.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.41 |
| LogP ≤ 5 | 2.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135255894 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.